Embed Size (px)
Citation preview
Covered in this Report
• This report covers the present scenario and the growthprospects of the Cystic Fibrosis market in Europe for the period2015-2019.
• To calculate the market size, the report considers the revenuegenerated from the sales of various generic and brandedtherapies used in the treatment of cystic fibrosis including:
• Small Molecules• Biologics
• TechNavio's report, Cystic Fibrosis Market in Europe 2015-2019,has been prepared based on an in-depth market analysis withinputs from industry experts.
• The report covers data from Europe; it also covers the marketlandscape of the Cystic Fibrosis market in Europe and its growthprospects over the coming years.
• The report also includes a discussion of the key vendorsoperating in this market.
Cystic Fibrosis Market in Europe 2015-2019
USA – CANADA – UK – CHINA – INDIA
Market Overview
• Cystic fibrosis, also known as mucoviscidosis, is a geneticallyinherited disease.
• The primary symptoms of cystic fibrosis include high saltcontent in the sweat, breathing difficulties, secretion ofabnormally viscous mucus, respiratory complications,difficulties related to digestion, and growth anomalies.
• It is significantly less common in Asian and African populationscompared to Caucasians, with a marked difference betweeneach country in those regions.
• The principal manifestations of cystic fibrosis in patients arechronic bronchitis, pancreatic insufficiency, adolescentdiabetes, pancreatitis, male sterility, and very rarely intestinalobstruction or liver cirrhosis.
• TechNavio's analysts forecast the Cystic Fibrosis market inEurope to grow at a CAGR of 35.10 percent over the period2014-2019.
To know more aboutCystic Fibrosis Market in Europe 2015-2019,
please mail us [email protected]
USA – CANADA – UK – CHINA – INDIA
Key Vendors and Regions
• Actavis
• F. Hoffmann-La Roche
• Gilead Sciences
• Novartis
• Vertex Pharmaceuticals
• Abbott
• Anthera Pharmaceuticals
• Arcturus Therapeutics
• Boehringer Ingelheim
• Chiesi Farmaceutici
View Our Report:Cystic Fibrosis Market in
Europe 2015-2019
• Europe
Vendors Regions
USA – CANADA – UK – CHINA – INDIA
Key Findings
• CFTR modulator drugs are fast becoming the preferred choice of treatmentfor cystic fibrosis among patients and the medical community.
• These drugs target the defects caused by CFTR gene mutations, i.e., thecause of the disease.
• Kalydeco is the only CFTR modulator drug that is approved and marketed forthe treatment of cystic fibrosis.
• Ivacaftor, an active ingredient of Kalydeco, is a CFTR potentiator drug.Another drug by the company, Lumacaftor, currently under Phase III trials, isalso a CFTR modulator drug.
USA – CANADA – UK – CHINA – INDIA
Key Questions Answered in Our Report
• What will the market size be in 2018 and what will thegrowth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats facedby the key vendors?
• What are the strengths and weaknesses of the keyvendors?
Have a question of your own about this report?
Ask our Analysts
USA – CANADA – UK – CHINA – INDIA
• Decision makers and influencers in sales & marketing, strategy, product and R&Dteams rely on research from TechNavio. We have a large and growing base ofhappy customers worldwide. Our customers include technology suppliers, endusers, consulting companies, investment firms and research institutes.
• TechNavio was founded in 2003 in London. We have about 300 analysts globally.We cover more than 500 technologies across 80 countries. Traditional media suchas Forbes Asia and New York Times, along with other web media portals, like toquote us.
About TechNavio
Some of our clients include:ACT Global, Flextronics, Huawei Technologies Co, Infosys,Harris Corporation, Infosys, Intercad, Hidaka PrecisionTools & Dies Company, Huawei Technologies Co, AmericanCapital, Analysis Group, Netscout, NTT DoCoMo
USA – CANADA – UK – CHINA – INDIA
View Our Report
Cystic Fibrosis Market in Europe 2015-2019
102 Pages | SKU: IRTNTR5271
For media enquiries,
please drop us a mail at
For more on the scopeof the report, mail us at
Thank You!
Mail us at: [email protected]
You can visit us at:www.technavio.com
USA – CANADA – UK – CHINA – INDIA
